Predictive factors for the development of cardiorenal syndrome in patients with heart failure
DOI:
https://doi.org/10.33448/rsd-v10i2.12090Keywords:
Cardiorenal syndrome; Predictive factors; Heart failure; Renal dysfunction.Abstract
Objective: to analyze, from a systematic review of the literature, what are the predictive factors for the development of cardiorrenal syndrome in patients with heart failure. Methods: a systematic review of the literature was performed from the research question "What are the predictive factors for the development of cardiorrenal syndrome in patients with heart failure? For the selection of the articles that compose this study, a search was made in the following databases: Medical Publisher (PUBMED), Virtual Health Library (VHL), Science Direct (SD) and Semantic Scholar, using as eligibility criteria only observational studies or randomized clinical trials that contemplated the research question, which were relevant and current to address the theme. The final sample is composed of 25 publications. Results: the main predictive factors for the development of cardiorrenal syndrome are associated with cardiovascular risk factors and manifestations generated from renal impairment. Conclusion: The junction of comorbidities of the patient, with risk factors for the development of cardiovascular disease, acute renal injury associated with laboratory markers of myocardial injury and renal injury can act as reliable predictive factors for the development of the cardiorrenal syndrome.
References
Acle, S., Ormaechea, G., Álvarez, P., Gadola, L., & Noboa, O. (2018). Función renal en pacientes ambulatorios con insuficiencia cardíaca con fracción de eyección reducida; análisis de su evolución e implicancia pronóstica. Seguimiento a 4 años en una Unidad Multidisciplinaria de Insuficiencia Cardíaca. Revista Uruguaya de Medicina Interna, 3(2), 4-11. http://dx.doi.org/10.26445/03.01.5.
Al-Hwiesh, A. K., Abdul-Rahman, I. S., Al-Audah, N., Al-Hwiesh, A., Al-Harbi, M., Taha, A. … Al-Audah, N. (2019). Tidal peritoneal dialysis versus ultrafiltration in type 1 cardiorenal syndrome: a prospective randomized study. The International Journal Of Artificial Organs, 42(12), 684-694. http://dx.doi.org/10.1177/0391398819860529.
Al-Jarallah, M., Rajan, R., Al-Zakwani, I., Dashti, R., Bulbanat, B., Sulaiman, K. … Suwaidi, J. A. (2018). Incidence and impact of cardiorenal anaemia syndrome on all-cause mortality in acute heart failure patients stratified by left ventricular ejection fraction in the Middle East. Esc Heart Failure, 6(1), 103-110. http://dx.doi.org/10.1002/ehf2.12351.
Andrade, T. A., Isidorio, U. A., Falcao, K. P. M., Andrade, M. N., Sousa, M. N. A., & Assis, E. V. (2014). Avaliação da qualidade de vida em pacientes com insuficiência renal crônica. Temas em Saúde (João Pessoa), 14(1), 236-249. http://temasemsaude.com/wp-content/uploads/2015/08/Edicao-01-20141.pdf
Borges Júnior, A. M., Figueiredo, J. P. M. P., & Sousa, A. B. de. (2020). Complicações apresentadas por pacientes com injúria renal aguda que utilizaram furosemida associada ou não a reposição de albumina. Research, Society and Development, 9(12), e20391211143. https://doi.org/10.33448/rsd-v9i12.11143.
Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Departamento de Ciência e Tecnologia. Diretrizes metodológicas: Sistema GRADE – Manual de graduação da qualidade da evidência e força de recomendação para tomada de decisão em saúde. Brasília: Ministério da Saúde; 2014. http://bvsms.saude.gov.br/bvs/publicacoes/diretrizes_metodologicas_sistema_grade.pdf.
Chimada, C. A., Silva, E. M. da, Otênio, J. K., Pinc, M. M., Jesus, R. A. de, Teixeira, D. G. ... Zardeto-Sabec, G. (2020). A importância do acompanhamento farmacoterapêutico em pacientes com insuficiência cardíaca. Research, Society and Development, 9(10), e1949108538. https://doi.org/10.33448/rsd-v9i10.8538.
Correia, D. M. da S., Cavalcanti, A. C. D., Queluci, G. C., Dias, B. F., Pimentel, A. C. E., Jorge, A. J. L. ... Rosa, M. L. G. (2020). Prevalência de diagnósticos de enfermagem prioritários em indivíduos segundo fatores de risco para insuficiência cardíaca na atenção primária. Research, Society and Development, 9(10), e9669109351. https://doi.org/10.33448/rsd-v9i10.9351.
Dantas, L. R. C. F., Jesus, C. V. F. de., Dantas, J. G. L., Martins, B. M., Almeida, A. O., Sousa, A. C. S. ... Lima, S. O. (2020). Tendências na hospitalização de pacientes com Insuficiência Cardíaca Aguda. Research, Society and Development, 9(9), e725997790. https://doi.org/10.33448/rsd-v9i9.7790.
Galvão, M. C. B., Ricarte I. L. M. (2019). Revisão sistemática da literatura: conceituação, produção e publicação. Logeion: Filosofia da Informação, 6(1), 57-73. https://doi.org/10.21728/logeion.2019v6n1.p57-73.
Galvão T. F., Pansani T. S. A., Harrad, D. (2015). Principais itens para relatar Revisões sistemáticas e Meta-análises: a recomendação prisma. Epidemiologia e Serviços de Saúde, 24(2), 335-342. http://dx.doi.org/10.5123/s1679-49742015000200017.
García-Blas, S., Bonanad, C., Llàcer, P., Ventura, S., Nðñez, J. M., Sánchez, R. ... Vaquer, J. M. (2017). Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: conventional vs carbohydrate antigen 125-guided strategy. clinical trial design. Revista Española de Cardiología (English Edition), 70(12), 1067-1073. http://dx.doi.org/10.1016/j.rec.2017.02.028.
Grodin, J. L., Carter, S., Bart, B. A., Goldsmith, S. R., Drazner, M. H. & Tang, W. H. W. (2018). Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of carress-hf. European Journal Of Heart Failure, 20(7), 1148-1156. http://dx.doi.org/10.1002/ejhf.1158.
Grossekettler, L., Schmack, B., Meyer, K., Brockmann, C., Wanninger, R., Kreusser, M. M. … Katus, H. A. (2019). Peritoneal dialysis as therapeutic option in heart failure patients. Esc Heart Failure, 6(2), 271-279. http://dx.doi.org/10.1002/ehf2.12411.
Inaguma, D., Koide, S., Takahashi, K., Hayashi, H., Hasegawa, M. & Yuzawa, Y., (2017). Relationship between history of coronary heart disease at dialysis initiation and onset of events associated with heart disease: a propensity-matched analysis of a prospective cohort study. Bmc Nephrology, 18(1), 1-8. http://dx.doi.org/10.1186/s12882-017-0495-8.
Jentzer, J. C., Bihorac, A., Brusca, S. B., Rio-Pertuz, G. del., Kashani, K., Kazory, A. ... Morrow, D. A. (2020). Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome. Journal Of The American College Of Cardiology, 76(9), 1084-1101. http://dx.doi.org/10.1016/j.jacc.2020.06.070.
Jung, H. H., (2019). Association of Optimal Blood Pressure With Critical Cardiorenal Events and Mortality in High-Risk and Low-Risk Patients Treated With Antihypertension Medications. Jama Network Open, 2(8), 1-12. http://dx.doi.org/10.1001/jamanetworkopen.2019.9307.
Kumar, U., WETTERSTEN, N., & GARIMELLA, P. S. (2019). Cardiorenal Syndrome. Cardiology Clinics, 37(3), 251-265. http://dx.doi.org/10.1016/j.ccl.2019.04.001.
Lannemyr, L., Ricksten, S., Rundqvist, B., Andersson, B., Bartfay, S., Ljungman, C. … Gilljam, T. (2018). Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment: a randomized double⠰blind controlled trial. Journal Of The American Heart Association, 7(16), 1-9. http://dx.doi.org/10.1161/jaha.117.008455.
Legrand, M., Berardinis, B. de, Gaggin, H. K., Magrini, L., Belcher, A., Zancla, B. … Sambhare, R. (2014). Evidence of Uncoupling between Renal Dysfunction and Injury in Cardiorenal Syndrome: insights from the bionics study. Plos One, 9(11), 1-8. http://dx.doi.org/10.1371/journal.pone.0112313.
Li, J., Sheng, X., Cheng, D., Wang, F., Jian, G., Li, Y. ... Wang, N. (2018) Is the mean platelet volume a predictive marker of a high in-hospital mortality of acute cardiorenal syndrome patients receiving continuous renal replacement therapy? Medicine, 97(25), 1-5. http://dx.doi.org/10.1097/md.0000000000011180.
Linhart, C., Ulrich, C., Greinert, D., Dambeck, S., Wienke, A., Girndt, M. … Pliquett, R. U. (2018). Systemic inflammation in acute cardiorenal syndrome: an observational pilot study. Esc Heart Failure, 5(5), 920-930. http://dx.doi.org/10.1002/ehf2.12327.
Lullo, L. di, Bellasi, A., Barbera, V., Russo, D., Russo, L., Iorio, B. di ... Ronco, C. (2017). Pathophysiology of the cardio-renal syndromes types 1–5: an uptodate. Indian Heart Journal, 69(2), 255-265. http://dx.doi.org/10.1016/j.ihj.2017.01.005.
Matsushita, K., Kwak, L., Sang, Y., Ballew, S. H., Skali, H., Shah, A. M. ... Solomon, S. (2017). Kidney Disease Measures and Left Ventricular Structure and Function: the atherosclerosis risk in communities study. Journal Of The American Heart Association, 6(9), 1-20. http://dx.doi.org/10.1161/jaha.117.006259.
Mavrakanas, T. A., Khattak, A., Singh, K., & Charytan, D. M. (2017). Epidemiology and Natural History of the Cardiorenal Syndromes in a Cohort with Echocardiography. Clinical Journal Of The American Society Of Nephrology, 12(10), 1624-1633. http://dx.doi.org/10.2215/cjn.04020417.
Melo, W, F., Bezerra, A. L. D., Sousa, M. N. A. (2014). Perfil epidemiológico dos pacientes com insuficiência renal crônica: um estudo quantitativo. Ciência & Desenvolvimento-Revista Eletrônica da FAINOR, 7(2), 142 -156.
Ng, L. L., Squire, I. B., Jones, D. J. L., Cao, T. H., Chan, D. C. S., Sandhu, J. K. …Hartmann, O. (2017). Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure. Journal Of The American College Of Cardiology, 69(1), 56-69. http://dx.doi.org/10.1016/j.jacc.2016.10.038.
Pallangyo, P., Fredrick, F., Bhalia, S., Nicholaus, P., Kisenge, P., Mtinangi, B. … Humphrey, S. (2017). Cardiorenal Anemia Syndrome and Survival among Heart Failure Patients in Tanzania: a prospective cohort study. Bmc Cardiovascular Disorders, 17(1), 1-6. http://dx.doi.org/10.1186/s12872-017-0497-2.
Premuzic, V., Basic-Jukic, N., Jelakovic, B., & Kes, P. (2017). Continuous Veno-Venous Hemofiltration Improves Survival of Patients With Congestive Heart Failure and Cardiorenal Syndrome Compared to Slow Continuous Ultrafiltration. Therapeutic Apheresis And Dialysis, 21(3), 279-286. http://dx.doi.org/10.1111/1744-9987.12516.
Raina, R., Nair, N., Chakraborty, R., Nemer, L., Dasgupta, R., & Varian, K. (2020). An Update on the Pathophysiology and Treatment of Cardiorenal Syndrome. Cardiology Research, 11(2), 76-88. http://dx.doi.org/10.14740/cr955.
Rangaswami, J., & Mathew, Roy O. (2018). Pathophysiological Mechanisms in Cardiorenal Syndrome. Advances In Chronic Kidney Disease, 25(5), 400-407. http://dx.doi.org/10.1053/j.ackd.2018.08.006.
Reis, D. dos, Fraticelli, L., Bassand, A., Manzo-Silberman, S., Peschanski, N., Charpentier, S. ... Laribi, S. (2019). Impact of renal dysfunction on the management and outcome of acute heart failure: results from the french prospective, multicentre, defssica survey. Bmj Open, 9(1), 1-11. http://dx.doi.org/10.1136/bmjopen-2018-022776.
Robles, N. R., Campillejo, R. D., Valladares, J., Vinuesa, E. G. de, Villa, J., & Gervasini, G. (2020). Sacubitril-valsartan Improves Anemia of Cardiorenal Syndrome (CRS), Cardiovascular & Hematological Agents in Medicinal Chemistry, 18(X). https://doi.org/10.2174/1871525718666200506095537.
Savira, F., Magaye, R., Liew, D., Reid, C., Kelly, D. J., Kompa, A. R. … Wang, B. H. (2020). Cardiorenal syndrome: multi⠰organ dysfunction involving the heart, kidney and vasculature. British Journal Of Pharmacology, 177(13), 2906-2922. http://dx.doi.org/10.1111/bph.15065.
Shao, Q., Xia, Y., Zhao, M., Liu, J., Zhang, Q., Jin, B. ... Jiang, C. (2018). Effectiveness and Safety of Peritoneal Dialysis Treatment in Patients with Refractory Congestive Heart Failure due to Chronic Cardiorenal Syndrome. Biomed Research International, 2018(X), 1-9. http://dx.doi.org/10.1155/2018/6529283.
Siddaway, A. P., Wood, A. M., & Hedges, L. V. (2019). How to Do a Systematic Review: a best practice guide for conducting and reporting narrative reviews, meta-analyses, and meta-syntheses. Annual Review Of Psychology, 70(1), 747-770. http://dx.doi.org/10.1146/annurev-psych-010418-102803.
Siegenthaler, M., Huynh-Do, U., Krayenbuehl, P., Pollock, E., Widmer, U., Debaix, H. … Ruschitzka, F. (2017). Impact of cardio-renal syndrome on adverse outcomes in patients with Fabry disease in a long-term follow-up. International Journal Of Cardiology, 249(X), 261-267. http://dx.doi.org/10.1016/j.ijcard.2017.09.027.
Suresh, H., Arun, B.S., Moger, V., & Swamy, M. (2017). Cardiorenal syndrome type 4: a study of cardiovascular diseases in chronic kidney disease. Indian Heart Journal, 69(1), 11-16. http://dx.doi.org/10.1016/j.ihj.2016.07.006.
Uduman, Jr. (2018). Epidemiology of Cardiorenal Syndrome. Advances In Chronic Kidney Disease, 25(5), 391-399. http://dx.doi.org/10.1053/j.ackd.2018.08.009.
Verbrugge, F. H., Martens, P., Ameloot, K., Haemels, V., Penders, J., Dupont, M. … Mullens, W. (2018). Spironolactone to increase natriuresis in congestive heart failure with cardiorenal syndrome. Acta Cardiologica, 74(2), 100-107. http://dx.doi.org/10.1080/00015385.2018.1455947.
Virzì, G. M., Breglia, A., Castellani, C., Ankawi, G., Bolin, C., Cal, M. de ... Ronco, C. (2019). Lipopolysaccharide in systemic circulation induces activation of inflammatory response and oxidative stress in cardiorenal syndrome type 1. Journal Of Nephrology, 32(5), 803-810. http://dx.doi.org/10.1007/s40620-019-00613-2.
Watanabe, I., Tatebe, J., Fujii, T., Noike, R., Saito, D., Koike, H. ... Amano, H. (2019). Prognostic Significance of Serum Indoxyl Sulfate and Albumin for Patients with Cardiovascular Disease. International Heart Journal, 60(1), 129-135. http://dx.doi.org/10.1536/ihj.18-116.
Yogasundaram, H., Chappell, M. C., Braam, B., & Oudit, G. Y. (2019). Cardiorenal Syndrome and Heart Failure—Challenges and Opportunities. Canadian Journal Of Cardiology, 35(9), 1208-1219. http://dx.doi.org/10.1016/j.cjca.2019.04.002.
Zhang, D., Li, H., Chen, H., Ma, Q., Chen, H., Xing, Y., ... Zhao, X. (2018) Combination of Amino‐Terminal Pro‐BNP, Estimated GFR, and High‐Sensitivity CRP for Predicting Cardiorenal Syndrome Type 1 in Acute Myocardial Infarction Patients. Journal Of The American Heart Association, 7(19), 1-11. http://dx.doi.org/10.1161/jaha.118.009162.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Alexandre Henrique Costa Gonçalves; Milena Nunes Alves de Sousa; Tiago Bruno Carneiro de Farias
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
